Name
warf2
Label
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2))
Description

Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,470 -
Yes - - 150 -
Unknown - - 460 -
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,568 1,902 3,470
Yes 93 57 150
Unknown 200 260 460
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,028 232 210 3,470
Yes 134 10 6 150
Unknown 425 14 21 460